Neuroimaging at 7 T: are we ready for clinical transition?
Cerebrovascular diseases
Magnetic resonance imaging
Multiple sclerosis
Neurodegenerative diseases
Neuroimaging
Journal
European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752
Informations de publication
Date de publication:
26 08 2021
26 08 2021
Historique:
received:
10
06
2021
accepted:
19
07
2021
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
3
2
2022
Statut:
epublish
Résumé
In the last 20 years, ultra-high field (UHF) magnetic resonance imaging (MRI) has become an outstanding research tool for the study of the human brain, with 90 of these scanners installed today, worldwide. The recent clearances from regulatory bodies in the USA and Europe to 7-T clinical systems have set the ground for a transition from pure research applications to research and clinical use of these systems. As today, UFH neuroimaging is demonstrating clinical value and, given the importance of this topic for both preclinical scientists and clinical neuroradiologists, European Radiology Experimental is launching a thematic series entitled "7-T neuro MRI: from research to clinic", consisting of peer-reviewed articles, invited or spontaneously submitted, on topics selected by the guest editors, describing the state of the art of UHF MRI neuroimaging across different pathologies, as well as related clinical applications. In this editorial, we discuss some of the challenges related to the clinical use of 7-T scanners and the strengths and weaknesses of clinical imaging at UHF.
Identifiants
pubmed: 34435257
doi: 10.1186/s41747-021-00234-0
pii: 10.1186/s41747-021-00234-0
pmc: PMC8387509
doi:
Types de publication
Editorial
Introductory Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Informations de copyright
© 2021. The Author(s).
Références
Eur Radiol. 2017 Apr;27(4):1585-1595
pubmed: 27387876
J Cereb Blood Flow Metab. 2014 Oct;34(10):1715-9
pubmed: 25074748
AJNR Am J Neuroradiol. 2004 Oct;25(9):1628-9; author reply 1629
pubmed: 15502155
Mov Disord. 2014 Nov;29(13):1574-81
pubmed: 25308960
Neurology. 2021 Apr 20;96(16):e2048-e2057
pubmed: 33653897
Neuroimage. 2018 Mar;168:509-531
pubmed: 28179167
Eur Radiol Exp. 2020 Oct 22;4(1):59
pubmed: 33089380
AJNR Am J Neuroradiol. 2019 Jul;40(7):1106-1111
pubmed: 31147351
Epilepsia. 2020 Nov;61(11):2509-2520
pubmed: 32949471
Health Phys. 2020 May;118(5):483-524
pubmed: 32167495
Ann Neurol. 2018 Feb;83(2):283-294
pubmed: 29328521
Prog Nucl Magn Reson Spectrosc. 2018 Dec;109:1-50
pubmed: 30527132
J Neurosurg. 2010 Sep;113(3):639-47
pubmed: 20380532
Mov Disord. 2011 Mar;26(4):713-8
pubmed: 21506148
World Neurosurg. 2016 Sep;93:410-2
pubmed: 27368505
Top Magn Reson Imaging. 2016 Apr;25(2):89-100
pubmed: 27049246
Neuroimage. 2011 Oct 1;58(3):741-8
pubmed: 21726652
AJR Am J Roentgenol. 2014 Feb;202(2):401-5
pubmed: 24450683
Eur Radiol. 2020 Aug;30(8):4586-4594
pubmed: 32211962
Neuroimage. 2018 Mar;168:345-357
pubmed: 28093360
Neurology. 2021 Feb 16;96(7):327-341
pubmed: 33361257
AJNR Am J Neuroradiol. 2020 Jan;41(1):2-9
pubmed: 31879330
Invest Radiol. 2014 May;49(5):249-59
pubmed: 24637589
Nat Rev Neurol. 2016 Jun;12(6):358-68
pubmed: 27125632
AJNR Am J Neuroradiol. 2004 Feb;25(2):168-9
pubmed: 14970013
Magn Reson Med. 2001 Apr;45(4):588-94
pubmed: 11283986
AJNR Am J Neuroradiol. 2016 Mar;37(3):455-61
pubmed: 26680464
AJNR Am J Neuroradiol. 2016 Jun;37(6):1050-7
pubmed: 26846925
Neuroimage. 2018 Mar;168:412-426
pubmed: 28232189
J Magn Reson Imaging. 2016 Oct;44(4):1048-55
pubmed: 27042956
Magn Reson Med. 2004 Aug;52(2):376-90
pubmed: 15282821
PLoS One. 2015 Mar 16;10(3):e0121051
pubmed: 25774881
AJNR Am J Neuroradiol. 2004 Oct;25(9):1626-7; author reply 1629
pubmed: 15502154
J Magn Reson Imaging. 2021 Feb;53(2):333-346
pubmed: 32830900